
    
      The primary objective of the clinical investigation is to assess the use of the thoracic
      bifurcation and the visceral manifold to repair thoracoabdominal aortic aneurysms in patients
      having appropriate anatomy. The primary intent of the study is to assess safety (i.e. freedom
      from major adverse events (MAE) at 30 days) and preliminary effectiveness (i.e., treatment
      success and technical success) of the device (i.e., the proportion of treatment group
      subjects that achieve and maintain treatment success at one year). Additionally, the study
      will assess technical success and treatment success at each follow-up interval.
    
  